Search research articles

ABOUT JoVE

Overview Leadership Blog JoVE Help Center

AUTHORS

Publishing Process Editorial Board Scope & Policies Peer Review FAQ Submit

LIBRARIANS

Testimonials Subscriptions Access Resources Library Advisory Board FAQ

RESEARCH

JoVE Journal Methods Collections JoVE Encyclopedia of Experiments Archive

EDUCATION

JoVE Core JoVE Business JoVE Science Education JoVE Lab Manual Faculty Resource Center Faculty Site

Terms & Conditions of Use

Related Concept Videos

Type II Diabetes II: Pathophysiology

Type II Diabetes II: Pathophysiology

PathophysiologyType 2 diabetes mellitus (T2DM ) is a chronic metabolic disorder characterized by insulin resistance and progressive pancreatic β-cell dysfunction, leading to impaired glucose homeostasis. It results from interactions among genetic predisposition, environmental factors, and metabolic stressors, such as overnutrition and a sedentary lifestyle.Insulin Resistance and Glucose DysregulationEarly T2DM involves insulin resistance in skeletal muscle, adipose tissue, and the liver.

Pathophysiology of Diabetes

Pathophysiology of Diabetes

Diabetes mellitus is a chronic metabolic disorder characterized by hyperglycemia. The four categories of diabetes are type 1 diabetes, type 2 diabetes, other specific types of diabetes, and gestational diabetes.
Type 1 diabetes is characterized by autoimmune-mediated destruction of pancreatic β cells, with environmental factors potentially triggering this process in genetically susceptible individuals. Despite many not having a family history, certain genes increase susceptibility, suggesting a...

Diabetes Mellitus: Overview and Type I Subtype

Diabetes Mellitus: Overview and Type I Subtype

Diabetes mellitus is a chronic metabolic disorder characterized by high blood glucose levels due to inadequate insulin production, insulin resistance, or both. The condition affects millions worldwide and can significantly impact their health and quality of life.
Type 1 diabetes is an autoimmune disease in which the immune system mistakenly attacks and destroys the insulin-producing beta cells in the pancreas. As a result, the body is unable to produce sufficient insulin, and individuals with...

Diabetic Neuropathy

Diabetic Neuropathy

DefinitionDiabetic neuropathy is nerve damage caused by long-standing diabetes mellitus. It results directly from prolonged high blood sugar levels.PathophysiologyThe pathophysiology of diabetic neuropathy involves both metabolic and vascular disturbances triggered by chronic hyperglycemia.Metabolic injury: Elevated glucose levels activate the polyol pathway within nerve cells, leading to the accumulation of sorbitol and fructose. This increases oxidative stress, disrupts normal nerve...

Complications of Diabetes Mellitus

Complications of Diabetes Mellitus

Diabetes mellitus is a chronic metabolic disorder characterized by persistent hyperglycemia due to insulin deficiency, resistance, or both. Prolonged hyperglycemia disrupts metabolic homeostasis and leads to acute and chronic complications.Acute ComplicationsAcute complications result from sudden metabolic imbalance.Diabetic ketoacidosis (DKA) mainly appears in type 1 diabetes but may also develop in type 2 diabetes, particularly under extreme stress. It arises from severe insulin deficiency,...

Diabetes Mellitus: Introduction

Diabetes Mellitus: Introduction

Diabetes mellitus consists of chronic metabolic disorders characterized by persistent hyperglycemia. This elevated blood glucose results from defects in insulin secretion, impaired insulin action, or both. Insulin, produced by pancreatic β-cells, is essential for maintaining glucose homeostasis by facilitating cellular glucose uptake for energy or storage. Disruptions in insulin production or function lead to glucose accumulation in the bloodstream, causing the clinical features and long-term...

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by

Same author

The pattern of incident fractures according to fracture site in people with T1D.

Osteoporosis international : a journal established as result of cooperation between the European Foundation for Osteoporosis and the National Osteoporosis Foundation of the USA·2021

Same author

Impact of aging and exercise on skeletal muscle mitochondrial capacity, energy metabolism, and physical function.

Nature communications·2021

Same author

NAD+-Precursor Supplementation With L-Tryptophan, Nicotinic Acid, and Nicotinamide Does Not Affect Mitochondrial Function or Skeletal Muscle Function in Physically Compromised Older Adults.

The Journal of nutrition·2021

Same author

Association of physical activity and sedentary time with structural brain networks-The Maastricht Study.

GeroScience·2020

Same author

Burden of disease of type 2 diabetes mellitus: cost of illness and quality of life estimated using the Maastricht Study.

Diabetic medicine : a journal of the British Diabetic Association·2020

Same author

Fasting and post-oral-glucose-load levels of methylglyoxal are associated with microvascular, but not macrovascular, disease in individuals with and without (pre)diabetes: The Maastricht Study.

Diabetes & metabolism·2020

Search research articles

Related Experiment Video

Updated: May 27, 2026

A Protocol for Constructing a Rat Wound Model of Type 1 Diabetes

A Protocol for Constructing a Rat Wound Model of Type 1 Diabetes

Published on: February 17, 2023

Diabetes: impaired damage control.

N C Schaper¹, B Havekes

¹Department of Internal Medicine, Division of Endocrinology, Maastricht University Medical Centre, PO Box 5600, 6202 AZ Maastricht, The Netherlands. n.schaper@mumc.nl

|November 15, 2011

Summary

Diabetes impairs tissue repair by altering danger signals, leading to excessive tissue loss and complications like heart failure and poor wound healing. High mobility group box 1 (HMGB1) is implicated, with potential benefits from dipeptidyl peptidase IV (DPP-IV) inhibition.

More Related Videos

An Assay to Detect Protection of the Retinal Vasculature from Diabetes-Related Death in Mice

An Assay to Detect Protection of the Retinal Vasculature from Diabetes-Related Death in Mice

Published on: January 12, 2024

Related Experiment Videos

Last Updated: May 27, 2026

A Protocol for Constructing a Rat Wound Model of Type 1 Diabetes

A Protocol for Constructing a Rat Wound Model of Type 1 Diabetes

Published on: February 17, 2023

An Assay to Detect Protection of the Retinal Vasculature from Diabetes-Related Death in Mice

An Assay to Detect Protection of the Retinal Vasculature from Diabetes-Related Death in Mice

Published on: January 12, 2024

Area of Science:

Immunology
Endocrinology
Cardiovascular Science

Background:

Tissue damage triggers coordinated innate immune, circulatory, and nervous system responses for repair.
Diabetes mellitus alters danger signals, leading to compromised tissue repair and increased injury severity.
Complications include cardiac failure post-myocardial infarction, severe peripheral ischemia, and impaired wound healing.

Purpose of the Study:

To discuss the mechanisms of impaired damage control in diabetes.
To emphasize the role of high mobility group box 1 (HMGB1) in diabetes-related tissue damage.
To explore the potential of dipeptidyl peptidase IV (DPP-IV) inhibition in enhancing repair.

Main Methods:

Review of existing literature on diabetes, tissue repair, and immune responses.
Focus on the molecular mechanisms involving danger signals and inflammatory cytokines.
Discussion of therapeutic targets such as HMGB1 and DPP-IV.

Main Results:

Diabetes-induced alterations in danger signals disrupt the coordinated repair response.
The proinflammatory cytokine HMGB1 plays a significant role in excessive tissue loss and poor repair.
DPP-IV inhibition presents a potential therapeutic strategy to improve repair mechanisms.

Conclusions:

Impaired damage control in diabetes, driven by altered danger signals and HMGB1, exacerbates tissue injury.
Targeting HMGB1 and utilizing DPP-IV inhibition may offer novel therapeutic avenues for improving tissue repair in diabetic patients.